TY - JOUR
T1 - Effect of a Mobile Health Application with Nurse Support on Quality of Life among Community-Dwelling Older Adults in Hong Kong
T2 - A Randomized Clinical Trial
AU - Wong, Arkers Kwan Ching
AU - Wong, Frances Kam Yuet
AU - Chow, Karen Kit Sum
AU - Wong, Siu Man
AU - Bayuo, Jonathan
AU - Ho, Annie Ka Ying
N1 - Publisher Copyright:
© 2022 American Medical Association. All rights reserved.
PY - 2022/11/9
Y1 - 2022/11/9
N2 - Importance: Mobile health (mHealth) smartphone apps are becoming increasingly popular among older adults, although the reactive care approach of these apps has limited their usability. Objective: To evaluate the effects of an interactive mHealth program supported by a health-social partnership team on quality of life (QOL) among community-dwelling older adults in Hong Kong. Design, Setting, and Participants: This was a 3-group, randomized clinical trial conducted in 5 community centers in Hong Kong from December 1, 2020, to April 30, 2022, with a last follow-up date of January 31, 2022. Participants included older adults aged at least 60 years who were living within the service area, used a smartphone, and had at least 1 of the following problems: chronic pain, hypertension, or diabetes. Data were analyzed from May 1 to 10, 2022. Interventions: Participants were randomly assigned to the mHealth with interactivity (mHealth+I) group, mHealth group, or control group. Participants in the mHealth+I group received the mHealth app and nurse case management supported by a health-social partnership team. The mHealth group received the mHealth app only. The control group received no mHealth app or health-social care services. Main Outcomes and Measures: The primary outcome was the change in QOL from baseline to 3 months after completion of the intervention. Results: Among 221 participants (mean [SD] age 76.6 [8.0] years; 185 [83.7%] women), 76 were randomized to the control group, 71 were randomized to the mHealth group, and 74 were randomized to the mHealth+I group. The most common chronic diseases or problems were hypertension (147 participants [66.5%]), pain (144 participants [65.2%]), cataracts (72 participants [32.6%]), and diabetes (61 participants [27.6%]). At 3 months after the intervention and compared with the intervention group, there were no statistically significant differences in either the physical component summary (mHealth+I: β = -1.01 [95% CI, -4.13 to 2.11]; P =.53; mHealth: β = 0.22 [95% CI, -3.07 to 3.50]; P =.90) or the mental component summary (mHealth+I: β = -0.87 [95% CI, -4.42 to 2.69]; P =.63; mHealth: β = 1.73 [95% CI, -1.89 to 5.34]; P =.35) QOL scores. Only secondary outcomes, including self-efficacy (β = -2.31 [95% CI, -4.26 to -0.36]; P =.02), systolic blood pressure (β = -2.30 [95% CI, -5.00 to -0.13]; P =.04), pain levels (β = 1.18 [95% CI, 0.52 to 2.00]; P =.02), and health services utilization (β = 0.98 [95% CI, 0.32 to 2.09]; P =.048) improved in the mHealth+I group compared with the control group. Conclusions and Relevance: This randomized clinical trial found no difference in the primary outcome between the mHealth+I group and the control group confirming that there were no incremental benefits to adding interactivity in mHealth programs for older adults with chronic diseases. Trial Registration: Clinicaltrials.gov Identifier: NCT03878212.
AB - Importance: Mobile health (mHealth) smartphone apps are becoming increasingly popular among older adults, although the reactive care approach of these apps has limited their usability. Objective: To evaluate the effects of an interactive mHealth program supported by a health-social partnership team on quality of life (QOL) among community-dwelling older adults in Hong Kong. Design, Setting, and Participants: This was a 3-group, randomized clinical trial conducted in 5 community centers in Hong Kong from December 1, 2020, to April 30, 2022, with a last follow-up date of January 31, 2022. Participants included older adults aged at least 60 years who were living within the service area, used a smartphone, and had at least 1 of the following problems: chronic pain, hypertension, or diabetes. Data were analyzed from May 1 to 10, 2022. Interventions: Participants were randomly assigned to the mHealth with interactivity (mHealth+I) group, mHealth group, or control group. Participants in the mHealth+I group received the mHealth app and nurse case management supported by a health-social partnership team. The mHealth group received the mHealth app only. The control group received no mHealth app or health-social care services. Main Outcomes and Measures: The primary outcome was the change in QOL from baseline to 3 months after completion of the intervention. Results: Among 221 participants (mean [SD] age 76.6 [8.0] years; 185 [83.7%] women), 76 were randomized to the control group, 71 were randomized to the mHealth group, and 74 were randomized to the mHealth+I group. The most common chronic diseases or problems were hypertension (147 participants [66.5%]), pain (144 participants [65.2%]), cataracts (72 participants [32.6%]), and diabetes (61 participants [27.6%]). At 3 months after the intervention and compared with the intervention group, there were no statistically significant differences in either the physical component summary (mHealth+I: β = -1.01 [95% CI, -4.13 to 2.11]; P =.53; mHealth: β = 0.22 [95% CI, -3.07 to 3.50]; P =.90) or the mental component summary (mHealth+I: β = -0.87 [95% CI, -4.42 to 2.69]; P =.63; mHealth: β = 1.73 [95% CI, -1.89 to 5.34]; P =.35) QOL scores. Only secondary outcomes, including self-efficacy (β = -2.31 [95% CI, -4.26 to -0.36]; P =.02), systolic blood pressure (β = -2.30 [95% CI, -5.00 to -0.13]; P =.04), pain levels (β = 1.18 [95% CI, 0.52 to 2.00]; P =.02), and health services utilization (β = 0.98 [95% CI, 0.32 to 2.09]; P =.048) improved in the mHealth+I group compared with the control group. Conclusions and Relevance: This randomized clinical trial found no difference in the primary outcome between the mHealth+I group and the control group confirming that there were no incremental benefits to adding interactivity in mHealth programs for older adults with chronic diseases. Trial Registration: Clinicaltrials.gov Identifier: NCT03878212.
UR - https://www.scopus.com/pages/publications/85141510543
U2 - 10.1001/jamanetworkopen.2022.41137
DO - 10.1001/jamanetworkopen.2022.41137
M3 - Journal article
C2 - 36350651
AN - SCOPUS:85141510543
VL - 5
SP - E2241137
JO - JAMA network open
JF - JAMA network open
IS - 11
ER -